Programmed Death Ligand-1 Blocker drugs

3 medications in the FDA established pharmacologic class “Programmed Death Ligand-1 Blocker”.

DrugTypeNDC products
Imfinzi
Durvalumab
Rx2
Bavencio
avelumab
Rx1
Unloxcyt
cosibelimab
Rx1